Cerebrospinal fluid neopterin in paediatric neurology: A marker of active central nervous system inflammation

Developmental Medicine and Child Neurology

Volumn 51, Issue 4, 2009, Pages 317-323

  Dale, Russell C ^a,b   Brilot, Fabiene ^a   Fagan, Elizabeth ^b   Earl, John ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEOPTERIN; PTERIDINE;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD; CHRONIC DISEASE; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE MARKER; DYSTONIA; ENCEPHALITIS; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MYELITIS; NERVOUS SYSTEM INFLAMMATION; PLEOCYTOSIS; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RETROSPECTIVE STUDY; SEIZURE;

ADOLESCENT; BIOLOGICAL MARKERS; CENTRAL NERVOUS SYSTEM DISEASES; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; INFANT; LEUKOCYTOSIS; MALE; NEOPTERIN; NEUROLOGY; PEDIATRICS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC;

EID: 63249091078     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2008.03225.x     Document Type: Article

References (33)

1. Hoffmann G, Wirleitner B, Fuchs D. Potential role of immune system activation-associated production of neopterin derivatives in humans. Inflamm Res 2003; 52:313-21.
2. Furukawa Y, Nishi K, Kondo T, Tanabe K, Mizuno Y. Significance of CSF total neopterin and biopterin in inflammatory neurological diseases. J Neurol Sci 1992; 111:65-72.
3. Wirleitner B, Neurauter G, Schröcksnadel K, Frick B, Fuchs D. Interferon-gamma-induced conversion of tryptophan: Immunologic and neuropsychiatric aspects. Curr Med Chem 2003; 10:1581-91.
4. Millner MM, Franthal W, Thalhammer GH, et al. Neopterin concentrations in cerebrospinal fluid and serum as an aid in differentiating central nervous system and peripheral infections in children. Clin Chem 1998; 44:161-67.
5. Hyland K, Surtees RA, Heales SJ, Bowron A, Howells DW, Smith I. Cerebrospinal fluid concentrations of pterins and metabolites of serotonin and dopamine in a pediatric reference population. Pediatr Res 1993; 34:10-14.
6. Hagberg L, Dotevall L, Norkrans G, Larsson M, Wachter H, Fuchs D. Cerebrospinal fluid neopterin concentrations in central nervous system infection. J Infect Dis 1993; 168:1285-88.
7. Gisslen M, Hagberg L, Rosengren L, et al. Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: A combinatorial approach to use of cerebrospinal fluid molecular biomarkers. J Neuroimmune Pharmacol 2007; 2:112-19.
8. Surtees R, Hyland K, Smith I. Central-nervous-system methyl-group metabolism in children with neurological complications of HIV infection. Lancet 1990; 335:619-21.
9. Murata R, Hattori H, Matsuoka O, Nakajima T, Shintaku H. Ferritin, creatine kinase, and neopterin in subacute sclerosing panencephalitis. Brain Dev 1992; 14:391-95.
10. Maloney EM, St Claire Morgan O, Widner B, Werner ER, Fuchs D. Central nervous system activation of the indoleamine-2,3-dioxygenase pathway in human T cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis. J Infect Dis 2000; 181:2037-40.
11. Blau N, BonaféL, Krägeloh-Mann I, et al. Cerebrospinal fluid pterins and folates in Aicardi-Goutières syndrome: A new phenotype. Neurology 2003; 61:642-47.
12. Shaw CE, Dunbar PR, Macaulay HA, Neale TJ. Measurement of immune markers in the serum and cerebrospinal fluid of multiple sclerosis patients during clinical remission. J Neurol 1995; 242:53-58.
13. Fredrikson S, Eneroth P, Link H. Intrathecal production of neopterin in aseptic meningo-encephalitis and multiple sclerosis. Clin Exp Immunol 1987; 67:76-81.
14. Widner B, Leblhuber F, Fuchs D. Increased neopterin production and tryptophan degradation in advanced Parkinson's disease. J Neural Transm 2002; 109:181-89.
15. Lenzlinger PM, Hans VH, Jöller-Jemelka HI, Trentz O, Morganti-Kossmann MC, Kossmann T. Markers for cell-mediated immune response are elevated in cerebrospinal fluid and serum after severe traumatic brain injury in humans. J Neurotrauma 2001; 18: 479-89.
16. Mathiesen T, Fuchs D, Wachter H, von Holst H. Increased CSF neopterin levels in subarachnoid hemorrhage. J Neurosurg 1990; 73:69-71.
17. Fukushima T, Nixon JC. Analysis of reduced forms of biopterin in biological tissues and fluids. Anal Biochem 1980; 102:176-88.
18. Sawada Y, Shintaku H, Isshiki G. Neopterin and biopterin concentrations in cerebrospinal fluid in controls less than 1 year old. Brain Dev 1999; 21:264-67.
19. Kawakami Y, Fukunaga Y, Hashimoto K. [Changes of neopterin in cerebrospinal fluid and serum in children with meningitis]. No To Hattatsu 1996; 28:23-29. (In Japanese).
20. Nakazawa T. Cerebrospinal fluid neopterin levels in children with neurologic diseases. No To Hattatsu 1996; 28:291-98. (In Japanese).
21. Azumagawa K, Suzuki S, Tanabe T, Wakamiya E, Kawamura N, Tamai H. Neopterin, biopterin, and nitric oxide concentrations in the cerebrospinal fluid of children with central nervous system infections. Brain Dev 2003; 25:200-02.
22. Kawakami Y, Fukunaga Y, Kuwabara K, Fujita T, Fujino O, Hashimoto K. Clinical and immunological significance of neopterin measurement in cerebrospinal fluid in patients with febrile convulsions. Brain Dev 1999; 21:458-60.
23. Duarte S, Sanmarti F, Gonzalez V, et al. Cerebrospinal fluid pterins and neurotransmitters in early severe epileptic encephalopathies. Brain Dev 2008; 30:106-11.
24. Matsubara Y, Heininger JA, Lin YY. Improved diagnosis of classical vs atypical phenylketonuria by liquid chromatography. Clin Chem 1984; 30:278-80.
25. Dale RC, Webster R, Gill D. Contemporary encephalitis lethargica presenting with agitated catatonia, stereotypy, and dystonia-parkinsonism. Mov Disord 2007; 22:2281-84.
26. Pranzatelli MR, Hyland K, Tate ED, Arnold LA, Allison TJ, Soori GS. Evidence of cellular immune activation in children with opsoclonus-myoclonus: Cerebrospinal fluid neopterin. J Child Neurol 2004; 19:919-24.
27. Mackay GM, Forrest CM, Stoy N, et al. Tryptophan metabolism and oxidative stress in patients with chronic brain injury. Eur J Neurol 2006; 13:30-42.
28. Ploder M, Neurauter G, Spittler A, Schroecksnadel K, Roth E, Fuchs D. Serum phenylalanine in patients post trauma and with sepsis correlate to neopterin concentrations. Amino Acids 2008; 35:303-07.
29. McLean C, Ferriero D. Mechanisms of hypoxic-ischemic injury in the term infant. Semin Perinatol 2004; 28:425-32.
30. Lim MJ, Alexander N, Benedict JW, et al. IgG entry and deposition are components of the neuroimmune response in Batten disease. Neurobiol Dis 2007; 25:239-51.
31. Eichler F, Van Haren K. Immune response in leukodystrophies. Pediatr Neurol 2007; 37:235-44.
32. Vezzani A, Granata T. Brain inflammation in epilepsy: Experimental and clinical evidence. Epilepsia 2005; 46:1724-43.
33. Auvin S, Shin D, Mazarati A, Nakagawa J, Miyamoto J, Sankar R. Inflammation exacerbates seizure-induced injury in the immature brain. Epilepsia 2007; 48(Suppl 5):27-34.